Skip to main content
Premium Trial:

Request an Annual Quote

European Genome Browser Launches at Bielefeld University

NEW YORK (GenomeWeb News) – Germany's Bielefeld University is the new European host of a node of the Genome Browser, the web portal resource that has been a home for genomic data for more than a decade, the university said today.

The website, which has been hosted by the University of Southern California, Santa Cruz, since 2001, is used by geneticists, molecular biologists, and clinical investigators around the world. It enables scientific users to explore genetic information in a graphic representation, to zoom in or out on the data, read reports from other researchers, and upload their own gene sequences for comparison.

Bielefeld said that strong demand for the Genome Browser has strained the data link across the Atlantic Ocean, so a European node was necessary.

Bielefeld University’s Center for Biotechnology's Institute for Bioinformatics and the University Computing Center are paying for the operational costs of the new server, and the University of California is paying for its acquisition, installation, and servicing.

Bielefeld said it began hosting the browser this week.

The Scan

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.

Tumor Microenvironment Immune Score Provides Immunotherapy Response, Prognostic Insights

Using multiple in situ analyses and RNA sequence data, researchers in eBioMedicine have developed a score associated with immunotherapy response or survival.

CRISPR-Based Method for Finding Cancer-Associated Exosomal MicroRNAs in Blood

A team from China presents in ACS Sensors a liposome-mediated membrane fusion strategy for detecting miRNAs carried in exosomes in the blood with a CRISPR-mediated reporter system.

Drug Response Variants May Be Distinct in Somatic, Germline Samples

Based on variants from across 21 drug response genes, researchers in The Pharmacogenomics Journal suspect that tumor-only DNA sequences may miss drug response clues found in the germline.